H49.811

Clinical Causes: Genetic mutations affecting mitochondrial DNA Inheritance patterns that involve maternal transmission Accumulation of mitochondrial DNA deletions over time

Key Symptoms: Ptosis (drooping of the eyelid) in the right eye Weakness or limited movement of the right eye muscles, leading to strabismus or double vision Progressive loss of peripheral vision Pigmentary changes in the retina, which can impair vision Muscle weakness beyond the eyes, including weakness in limbs or face Proximal muscle weakness, making daily activities more challenging Potential hearing loss, cardiac conduction defects, or other neurological issues

Diagnosis Path: Diagnosing Kearns-Sayre syndrome involves a combination of clinical evaluations and laboratory tests. An ophthalmologist may assess vision and eye movements, noting specific abnormalities like ptosis and muscle weakness. Electrophysiological tests such as electroretinography can evaluate retinal function. Blood tests can identify elevated levels of certain enzymes, and genetic testing may reveal mitochondrial DNA deletions. Brain imaging studies, like MRI, might also be used to rule out other neurological conditions, especially if additional neurological symptoms are present.

Treatment Protocols: While there is no cure for Kearns-Sayre syndrome, treatment focuses on managing symptoms and preventing complications. This approach may include: - Regular eye examinations and peer support for visual impairment - Surgical interventions for eyelid drooping if necessary - Cardiac monitoring and management of conduction defects, possibly with pacemakers - Hearing aids if hearing loss occurs - Physical therapy to improve muscle strength and mobility - Monitoring for and addressing any neurological or systemic manifestations - Multidisciplinary care involving neurology, ophthalmology, cardiology, and other specialists Ongoing medical support is essential to address the evolving nature of the syndrome and improve patient outcomes.